HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its
third quarter 2012 financial results will be released before the market
opens on Tuesday, October 30, 2012 and will be available on Impax’s Web
site at www.impaxlabs.com.
The Company will host a conference call and live webcast with financial
analysts at 11:00 a.m., Eastern Time.
The live webcast will be accessible through the Investor Relations
section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers) beginning 10
minutes prior to the scheduled start of the call.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (855) 859-2056 (in the U.S.)
and (404) 537-3406 (international callers). The access conference code
is 39759746.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (NASDAQ: IPXL) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
Impax markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate,
Impax has developed marketing partnerships to fully leverage its
technology platform. Impax Laboratories is headquartered in Hayward,
California, and has a full range of capabilities in its Hayward,
Philadelphia and Taiwan facilities. For more information, please visit
the Company's Web site at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.